Pages

Tuesday, April 11, 2017

Faster FDA Drug Reviews Could Compromise Safety, Critics Warn

P&T Community-18 hours ago
In February, after speaking with top pharma executives at the White House, President Trump described the FDA's approval process as “slow and burdensome” ...